Further multivariate analysis demonstrated that WHO grade, HMGA1, and MYH9 expression significantly correlated with patient survival (P = 0.01, P = 0.002, and P < 0.001, respectively, Table 2), indicating that these three factors should be treated as independent prognostic factors in patients with glioma. This evidence concerns the gene HMGA1 and central nervous system cancer.